Login to Your Account

China Trials 10

Getting everyone on board for the imperfect process of clinical trial reform

By Shannon Ellis
Staff Writer

Friday, November 10, 2017

SHANGHAI – At China Trials 10, the optimism around the recent regulatory reforms – specifically those opening China to early stage and multiregional clinical trials – come with a hint of anxiety, as evidenced in the conference title: "Entering the New Era of China Clinical Development – Are We Ready?"

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription